These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6454482)

  • 1. Synergistic antileukemic activity of combinations of two nitrosoureas.
    Wheeler GP; Schabel FM; Trader MW
    Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
    Pouillart R; Huong TH; Brugerie E; Lheritier J
    Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo study of acute hematotoxicity of three nitrosoureas, chlorozotocin (chloro-2-ethyl)-ribofuranosyl-3-nitrosourea, and (chloro-2-ethyl)-1-ribopyranosyl-3-nitrosourea.
    Mori KJ; Jasmin C; Hayat M; MacDonald JS; Mathé G
    Cancer Res; 1980 Nov; 40(11):4282-6. PubMed ID: 6451285
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
    Kato T; Ota K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
    Schein PS; Panasci L; Woolley PV; Anderson T
    Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Heal JM; Fox PA; Doukas D; Schein PS
    Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy of L1210 mouse leukemia using a new water-soluble nitrosourea, 1-(2-chloroethyl)-3-(beta-d-glucopyranosyl)-1-nitrosourea, with various antimetabolites.
    Nagura E; Hoshino A; Sugihara T; Machida S
    Gan; 1980 Aug; 71(4):425-32. PubMed ID: 6448760
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cause of variability in activity of samples of CCNU against P388 leukemia in vivo.
    Montgomery JA
    Cancer Treat Rep; 1980; 64(8-9):987-91. PubMed ID: 7448833
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of structure and chemical activity on the ability of nitrosoureas to inhibit DNA repair.
    Kann HE; Schott MA; Petkas A
    Cancer Res; 1980 Jan; 40(1):50-5. PubMed ID: 6444211
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP; Montgomery JA
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract]   [Full Text] [Related]  

  • 16. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS; Hoth D; Schein PS
    Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
    Maral R; Bourut C; Chenu E; Mathe G; Bernon R; Lussan C; Imbach JL; Schein P; Bothorel P
    Oncology; 1985; 42(2):122-8. PubMed ID: 3157909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antileukemic effect of theophylline and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    DeWys WD; Bathina SH
    Cancer Res; 1980 Jul; 40(7):2202-8. PubMed ID: 6248198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA; Fox P; Schein PS
    Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.